H2020Индивидуална стипендия2018–2020

PHANTOM · Phenotypic screening the host antimicrobial responses towards the eradication of Mycobacterium tubercuosis

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период: 2018-10-01 → 2020-09-30
Финансиране от ЕС: 170 122 €
Участници: 1
Схема: MSCA-IF-EF-ST

Линиите свързват координатора с партньорите.

Накратко на български

Взаимодействието между имунната система на човека и бактерията Mycobacterium tuberculosis се анализира, за да се създаде система за доставка на лекарства само до заразените клетки. Това е важно, защото много сегашни терапии са неефективни поради нарастващата резистентност на бактериите.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Phenotypic screening the host antimicrobial responses towards the eradication of Mycobacterium tubercuosis

The co-evolution between hosts and their parasites is one of the most fascinating – yet still almost unexplored - examples of evolutionary adaptation. There is a paucity of information, however, on how the human immune system co-adapts to the parasites phenotypic plasticity, and how it dynamically rearranges its molecular phenotypes aiming to counteract the pathogenic threats. Hence, many therapies for the treatment of intracellular bacteria-related infections are currently obsolete, especially because of the rise in drug resistance. In this framework, the goal of my proposal was to decipher the unexplored phenotypic ‘bar-codes’ of host-pathogen interaction, to reversely engineer a drug delivery platform targeting infected cells only, and to eradicate intracellular parasites. The final aim will be the eradication of the severe intracellular pathogens Mycobacterium tuberculosis (Mtb), as is the major cause of mortality related to bacterial infection worldwide.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The co-evolution between hosts and their parasites is one of the most fascinating examples of evolutionary adaptation. However, there is a paucity of information on how the human immune system co-adapts to the parasites phenotypic plasticity, and how it dynamically rearranges its molecular phenotypes aiming to counteract the pathogenic threats. Hence, many therapies for the treatment of intracellular bacteria-related infection (e.g., tuberculosis) are currently obsolete, especially because of the rise in drug resistance. In this framework, the main goal of my proposal is to decipher the unexplored phenotype ‘bar-codes’ of host-pathogen interaction, in order to reversely engineer a drug delivery platform aiming to target infected cells only, and to eradicate intracellular parasites. The final aim will be that of eradicating the severe intracellular pathogens Mycobacterium tuberculosis (Mtb), as it is the major cause of mortality related to bacterial infection worldwide. According to the World Health Organisation, in fact, approximately one-third of the world’s population is asymptomatically affected by TB, with about 9 million new cases of per year (of which 11% are children under 15 years), and 1.4 million of deaths. Despite decades of control programs, TB is still second only to HIV as the greatest killer worldwide due to a single infectious agent (the average killing rate of TB is 3 people per minute). This project will thus explore the molecular bases of Mtb-host interaction. These investigations will be used to engineer 'super-selective' polymeric nanoparticles targeting infected cells only (thus avoiding side effects), and to eradicate intracellular parasite. This will be done while adopting strategies that counteract the development drug resistance. Hence, this project will avoid falling in what has been called as the potential new ‘Dark Middle Age” era of lack of antibiotics.

Оригинален текст от CORDIS (на английски).

Участници

FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA · BarcelonaКоординаторИспания